Controversies in the management of cancer-associated thrombosis
Authors:
- 21 November 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 10 (1) , 15-22
Abstract
Introduction: Cancer associated thrombosis (CAT) is a frequent complication among cancer patients. It is associated with increased morbidity, mortality, and psychological burden. Areas covered: Low-molecular-weight heparin monotherapy for the initial 6 months is considered the standard of care for the acute and long-term management of CAT. For patients at high risk of recurrent CAT (e.g. active cancer or still undergoing anticancer therapy) beyond the initial 6 months of treatment, continuation of anticoagulation therapy for secondary prevention is usually recommended. The management of anticoagulation therapy is more challenging in patients with cancer. Cancer patients are more likely to have recurrent events despite anticoagulation, thrombocytopenia due to their chemotherapy regimens or have incidental pulmonary embolism diagnosed on their staging imaging. Expert commentary: We will review expert consensuses and opinions in order to guide clinicians on how to tailor the management of CAT in these special circumstances.Keywords
This publication has 75 references indexed in Scilit:
- Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United StatesClinicoEconomics and Outcomes Research, 2013
- International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerJournal of Thrombosis and Haemostasis, 2012
- Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: A qualitative studyPalliative Medicine, 2012
- Venous thromboembolism and prognosis in cancerThrombosis Research, 2010
- Epidemiology and pathophysiology of cancer-associated thrombosisBritish Journal of Cancer, 2010
- Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM)Critical Reviews in Oncology/Hematology, 2006
- Pulmonary Embolism as a Cause of Death in Patients Who Died with CancerThe American Journal of Medicine, 2006
- Outcomes and Cost of Deep Venous Thrombosis Among Patients With CancerArchives of internal medicine (1960), 2004
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Prognosis of Cancers Associated with Venous ThromboembolismNew England Journal of Medicine, 2000